STOCK TITAN

[8-K] Sanmina Corp Reports Material Event

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

AgEagle Aerial Systems (NYSE American: UAVS) filed a Form S-3 shelf to register 7.7 million common shares for resale by Alpha Capital Anstalt. The stock originates from previously issued Series F Preferred Stock and ten tranches of common-stock warrants priced between $0.8294 and $2.19. No new shares are being sold by the company.

Cash impact: AgEagle will receive no direct proceeds from the resale. It could raise up to $7.7 million only if all outstanding warrants are exercised for cash; management makes no prediction on timing or certainty.

Dilution/overhang: If every underlying security converts or is exercised, outstanding shares would rise 23.6% to roughly 40.3 million, significantly diluting current holders and expanding free-float. A 9.99% ownership blocker limits Alpha’s voting power at any time.

  • Common shares outstanding (7/25/25): 32,563,677
  • Registration covers: 7,700,000 shares
  • Last close (7/29/25): $2.37

Use of proceeds: Any warrant-exercise cash would fund general corporate purposes. Risk factors stress dilution, resale pressure and future capital needs.

The filing preserves financing flexibility but introduces potential share-supply headwinds until the overhang is absorbed.

AgEagle Aerial Systems (NYSE American: UAVS) ha depositato un modulo S-3 per registrare 7,7 milioni di azioni ordinarie da rivendere da parte di Alpha Capital Anstalt. Le azioni derivano da azioni privilegiate Serie F emesse in precedenza e da dieci tranche di warrant su azioni ordinarie con prezzi compresi tra $0,8294 e $2,19. La società non sta vendendo nuove azioni.

Impatto finanziario: AgEagle non riceverà alcun ricavo diretto dalla rivendita. Potrebbe raccogliere fino a 7,7 milioni di dollari solo se tutti i warrant in circolazione verranno esercitati in contanti; il management non fornisce previsioni su tempi o certezza.

Diluizione/sovraccarico: Se tutti i titoli sottostanti venissero convertiti o esercitati, le azioni in circolazione aumenterebbero del 23,6%, raggiungendo circa 40,3 milioni, diluendo significativamente gli attuali azionisti e aumentando il flottante. Un limite di possesso del 9,99% impedisce ad Alpha di superare questa soglia di potere di voto in qualsiasi momento.

  • Azioni ordinarie in circolazione (25/7/25): 32.563.677
  • Registrazione copre: 7.700.000 azioni
  • Ultima chiusura (29/7/25): $2,37

Utilizzo dei proventi: Qualsiasi liquidità derivante dall'esercizio dei warrant sarà destinata a scopi societari generali. I fattori di rischio evidenziano diluizione, pressione di rivendita e future esigenze di capitale.

La registrazione mantiene la flessibilità finanziaria ma introduce potenziali ostacoli legati all'offerta di azioni fino a quando il sovraccarico non sarà assorbito.

AgEagle Aerial Systems (NYSE American: UAVS) presentó un formulario S-3 para registrar 7,7 millones de acciones ordinarias para reventa por parte de Alpha Capital Anstalt. Las acciones provienen de acciones preferentes Serie F emitidas previamente y de diez tramos de warrants sobre acciones ordinarias con precios entre $0.8294 y $2.19. La compañía no está vendiendo nuevas acciones.

Impacto en efectivo: AgEagle no recibirá ningún ingreso directo por la reventa. Podría recaudar hasta $7.7 millones solo si se ejercen en efectivo todos los warrants pendientes; la dirección no hace predicciones sobre el momento o la certeza.

Dilución/sobrecarga: Si todos los valores subyacentes se convierten o ejercitan, las acciones en circulación aumentarían un 23,6% a aproximadamente 40,3 millones, diluyendo significativamente a los accionistas actuales y aumentando el flotante. Un límite de propiedad del 9,99% restringe el poder de voto de Alpha en cualquier momento.

  • Acciones ordinarias en circulación (25/7/25): 32.563.677
  • Registro cubre: 7.700.000 acciones
  • Cierre último (29/7/25): $2.37

Uso de los ingresos: Cualquier efectivo proveniente del ejercicio de warrants se destinará a propósitos corporativos generales. Los factores de riesgo destacan la dilución, la presión de reventa y las necesidades futuras de capital.

La presentación preserva la flexibilidad financiera pero introduce posibles obstáculos de oferta de acciones hasta que se absorba la sobreoferta.

AgEagle Aerial Systems(NYSE American: UAVS)는 Alpha Capital Anstalt의 재판매를 위해 770만 보통주를 등록하는 S-3 양식을 제출했습니다. 해당 주식은 이전에 발행된 F 시리즈 우선주와 주당 $0.8294에서 $2.19 사이로 가격이 책정된 10회차 보통주 워런트에서 기인합니다. 회사는 새로운 주식을 판매하지 않습니다.

현금 영향: AgEagle는 재판매로부터 직접적인 수익을 받지 않습니다. 모든 미행사 워런트가 현금으로 행사될 경우 최대 770만 달러를 조달할 수 있지만, 경영진은 시기나 확실성에 대해 예측하지 않습니다.

희석/과잉 공급: 모든 기초 증권이 전환 또는 행사되면, 발행 주식 수는 23.6% 증가하여 약 4,030만 주가 되어 현재 주주들을 크게 희석시키고 유동주식 수를 늘리게 됩니다. 9.99% 소유 제한은 Alpha의 의결권을 언제든지 제한합니다.

  • 발행 보통주 (2025년 7월 25일 기준): 32,563,677주
  • 등록 대상: 7,700,000주
  • 마감가 (2025년 7월 29일): $2.37

수익금 사용: 워런트 행사로 인한 현금은 일반 기업 목적에 사용됩니다. 위험 요인에는 희석, 재판매 압력 및 미래 자본 필요성이 강조됩니다.

이번 등록은 재무 유연성을 유지하지만, 과잉 공급이 해소될 때까지 잠재적인 주식 공급 압력을 초래할 수 있습니다.

AgEagle Aerial Systems (NYSE American : UAVS) a déposé un formulaire S-3 pour enregistrer 7,7 millions d'actions ordinaires en vue d'une revente par Alpha Capital Anstalt. Les actions proviennent d'actions privilégiées de la série F émises précédemment et de dix tranches de bons de souscription d'actions ordinaires, dont le prix varie entre 0,8294 $ et 2,19 $. La société ne vend pas de nouvelles actions.

Impact sur la trésorerie : AgEagle ne recevra aucun produit direct de la revente. Elle pourrait lever jusqu'à 7,7 millions de dollars uniquement si tous les bons en circulation sont exercés en espèces ; la direction ne fait aucune prévision quant au calendrier ou à la certitude.

Dilution/surplomb : Si tous les titres sous-jacents sont convertis ou exercés, le nombre d'actions en circulation augmenterait de 23,6 % pour atteindre environ 40,3 millions, diluant significativement les actionnaires actuels et augmentant le flottant. Un plafond de détention de 9,99 % limite le pouvoir de vote d'Alpha à tout moment.

  • Actions ordinaires en circulation (25/07/25) : 32 563 677
  • Enregistrement couvre : 7 700 000 actions
  • Dernière clôture (29/07/25) : 2,37 $

Utilisation des produits : Tout produit en espèces provenant de l'exercice des bons servirait à des fins générales d'entreprise. Les facteurs de risque soulignent la dilution, la pression de revente et les besoins futurs en capitaux.

Le dépôt préserve la flexibilité financière mais introduit des vents contraires potentiels liés à l'offre d'actions jusqu'à absorption du surplomb.

AgEagle Aerial Systems (NYSE American: UAVS) hat ein Formular S-3 eingereicht, um 7,7 Millionen Stammaktien zum Weiterverkauf durch Alpha Capital Anstalt zu registrieren. Die Aktien stammen aus zuvor ausgegebenen Series F Vorzugsaktien und zehn Tranchen von Stammaktien-Warrants mit Preisen zwischen 0,8294 und 2,19 USD. Das Unternehmen verkauft keine neuen Aktien.

Bargeldwirkung: AgEagle erhält keine direkten Erlöse aus dem Weiterverkauf. Es könnten bis zu 7,7 Millionen USD nur erzielt werden, wenn alle ausstehenden Warrants bar ausgeübt werden; die Geschäftsleitung macht keine Vorhersage bezüglich Zeitpunkt oder Sicherheit.

Verwässerung/Überhang: Wenn alle zugrunde liegenden Wertpapiere umgewandelt oder ausgeübt werden, würden die ausstehenden Aktien um 23,6 % auf etwa 40,3 Millionen steigen, was die aktuellen Inhaber erheblich verwässert und den Free Float erweitert. Eine 9,99%-Besitzgrenze begrenzt Alphas Stimmrecht jederzeit.

  • Ausstehende Stammaktien (25.07.25): 32.563.677
  • Registrierung umfasst: 7.700.000 Aktien
  • Letzter Schlusskurs (29.07.25): 2,37 USD

Verwendung der Erlöse: Jegliche Bargelderlöse aus der Ausübung von Warrants würden für allgemeine Unternehmenszwecke verwendet. Risikofaktoren heben Verwässerung, Verkaufsdruck und zukünftigen Kapitalbedarf hervor.

Die Einreichung bewahrt die finanzielle Flexibilität, bringt jedoch potenzielle Gegenwinde durch das Aktienangebot, bis der Überhang absorbiert ist.

Positive
  • Potential $7.7 million cash infusion if all warrants are exercised at prices averaging ~$1.28, below current market, improving liquidity without debt.
Negative
  • Registration adds up to 23.6% share dilution, creating a sizable overhang that could depress pricing.
  • Company receives no immediate proceeds; funding benefit is contingent on warrant holders electing cash exercise.
  • Resale by a single holder (Alpha Capital Anstalt) may concentrate selling pressure despite a 9.99% blocker.

Insights

TL;DR: Resale shelf adds 24% potential dilution; cash inflow only if warrants exercised; neutral-to-negative for existing holders.

The S-3 registers legacy preferred and warrant shares, creating a sizeable overhang without guaranteeing liquidity for the company. While $7.7 million could enter the treasury, the weighted-average warrant price (~$1.28) sits below the recent $2.37 close, so exercise is plausible. Nonetheless, the 23.6% incremental float may pressure the share price until digested. Because no immediate capital is raised, the filing does little to improve near-term cash runway. Overall capital-markets housekeeping, but modestly dilutive.

TL;DR: Routine Rule 415 resale shelf; key items are 9.99% blocker and GSA/BVLOS achievements remain unaffected.

The document follows standard Section 5 protocol, clearly delineating that AgEagle is a smaller reporting company and a non-accelerated filer. It invokes Rule 415 for continuous offerings and embeds typical Nevada indemnification language. The 9.99% blocker mitigates control issues but not market supply. Legal risk is low; main investor concern is dilution rather than compliance.

AgEagle Aerial Systems (NYSE American: UAVS) ha depositato un modulo S-3 per registrare 7,7 milioni di azioni ordinarie da rivendere da parte di Alpha Capital Anstalt. Le azioni derivano da azioni privilegiate Serie F emesse in precedenza e da dieci tranche di warrant su azioni ordinarie con prezzi compresi tra $0,8294 e $2,19. La società non sta vendendo nuove azioni.

Impatto finanziario: AgEagle non riceverà alcun ricavo diretto dalla rivendita. Potrebbe raccogliere fino a 7,7 milioni di dollari solo se tutti i warrant in circolazione verranno esercitati in contanti; il management non fornisce previsioni su tempi o certezza.

Diluizione/sovraccarico: Se tutti i titoli sottostanti venissero convertiti o esercitati, le azioni in circolazione aumenterebbero del 23,6%, raggiungendo circa 40,3 milioni, diluendo significativamente gli attuali azionisti e aumentando il flottante. Un limite di possesso del 9,99% impedisce ad Alpha di superare questa soglia di potere di voto in qualsiasi momento.

  • Azioni ordinarie in circolazione (25/7/25): 32.563.677
  • Registrazione copre: 7.700.000 azioni
  • Ultima chiusura (29/7/25): $2,37

Utilizzo dei proventi: Qualsiasi liquidità derivante dall'esercizio dei warrant sarà destinata a scopi societari generali. I fattori di rischio evidenziano diluizione, pressione di rivendita e future esigenze di capitale.

La registrazione mantiene la flessibilità finanziaria ma introduce potenziali ostacoli legati all'offerta di azioni fino a quando il sovraccarico non sarà assorbito.

AgEagle Aerial Systems (NYSE American: UAVS) presentó un formulario S-3 para registrar 7,7 millones de acciones ordinarias para reventa por parte de Alpha Capital Anstalt. Las acciones provienen de acciones preferentes Serie F emitidas previamente y de diez tramos de warrants sobre acciones ordinarias con precios entre $0.8294 y $2.19. La compañía no está vendiendo nuevas acciones.

Impacto en efectivo: AgEagle no recibirá ningún ingreso directo por la reventa. Podría recaudar hasta $7.7 millones solo si se ejercen en efectivo todos los warrants pendientes; la dirección no hace predicciones sobre el momento o la certeza.

Dilución/sobrecarga: Si todos los valores subyacentes se convierten o ejercitan, las acciones en circulación aumentarían un 23,6% a aproximadamente 40,3 millones, diluyendo significativamente a los accionistas actuales y aumentando el flotante. Un límite de propiedad del 9,99% restringe el poder de voto de Alpha en cualquier momento.

  • Acciones ordinarias en circulación (25/7/25): 32.563.677
  • Registro cubre: 7.700.000 acciones
  • Cierre último (29/7/25): $2.37

Uso de los ingresos: Cualquier efectivo proveniente del ejercicio de warrants se destinará a propósitos corporativos generales. Los factores de riesgo destacan la dilución, la presión de reventa y las necesidades futuras de capital.

La presentación preserva la flexibilidad financiera pero introduce posibles obstáculos de oferta de acciones hasta que se absorba la sobreoferta.

AgEagle Aerial Systems(NYSE American: UAVS)는 Alpha Capital Anstalt의 재판매를 위해 770만 보통주를 등록하는 S-3 양식을 제출했습니다. 해당 주식은 이전에 발행된 F 시리즈 우선주와 주당 $0.8294에서 $2.19 사이로 가격이 책정된 10회차 보통주 워런트에서 기인합니다. 회사는 새로운 주식을 판매하지 않습니다.

현금 영향: AgEagle는 재판매로부터 직접적인 수익을 받지 않습니다. 모든 미행사 워런트가 현금으로 행사될 경우 최대 770만 달러를 조달할 수 있지만, 경영진은 시기나 확실성에 대해 예측하지 않습니다.

희석/과잉 공급: 모든 기초 증권이 전환 또는 행사되면, 발행 주식 수는 23.6% 증가하여 약 4,030만 주가 되어 현재 주주들을 크게 희석시키고 유동주식 수를 늘리게 됩니다. 9.99% 소유 제한은 Alpha의 의결권을 언제든지 제한합니다.

  • 발행 보통주 (2025년 7월 25일 기준): 32,563,677주
  • 등록 대상: 7,700,000주
  • 마감가 (2025년 7월 29일): $2.37

수익금 사용: 워런트 행사로 인한 현금은 일반 기업 목적에 사용됩니다. 위험 요인에는 희석, 재판매 압력 및 미래 자본 필요성이 강조됩니다.

이번 등록은 재무 유연성을 유지하지만, 과잉 공급이 해소될 때까지 잠재적인 주식 공급 압력을 초래할 수 있습니다.

AgEagle Aerial Systems (NYSE American : UAVS) a déposé un formulaire S-3 pour enregistrer 7,7 millions d'actions ordinaires en vue d'une revente par Alpha Capital Anstalt. Les actions proviennent d'actions privilégiées de la série F émises précédemment et de dix tranches de bons de souscription d'actions ordinaires, dont le prix varie entre 0,8294 $ et 2,19 $. La société ne vend pas de nouvelles actions.

Impact sur la trésorerie : AgEagle ne recevra aucun produit direct de la revente. Elle pourrait lever jusqu'à 7,7 millions de dollars uniquement si tous les bons en circulation sont exercés en espèces ; la direction ne fait aucune prévision quant au calendrier ou à la certitude.

Dilution/surplomb : Si tous les titres sous-jacents sont convertis ou exercés, le nombre d'actions en circulation augmenterait de 23,6 % pour atteindre environ 40,3 millions, diluant significativement les actionnaires actuels et augmentant le flottant. Un plafond de détention de 9,99 % limite le pouvoir de vote d'Alpha à tout moment.

  • Actions ordinaires en circulation (25/07/25) : 32 563 677
  • Enregistrement couvre : 7 700 000 actions
  • Dernière clôture (29/07/25) : 2,37 $

Utilisation des produits : Tout produit en espèces provenant de l'exercice des bons servirait à des fins générales d'entreprise. Les facteurs de risque soulignent la dilution, la pression de revente et les besoins futurs en capitaux.

Le dépôt préserve la flexibilité financière mais introduit des vents contraires potentiels liés à l'offre d'actions jusqu'à absorption du surplomb.

AgEagle Aerial Systems (NYSE American: UAVS) hat ein Formular S-3 eingereicht, um 7,7 Millionen Stammaktien zum Weiterverkauf durch Alpha Capital Anstalt zu registrieren. Die Aktien stammen aus zuvor ausgegebenen Series F Vorzugsaktien und zehn Tranchen von Stammaktien-Warrants mit Preisen zwischen 0,8294 und 2,19 USD. Das Unternehmen verkauft keine neuen Aktien.

Bargeldwirkung: AgEagle erhält keine direkten Erlöse aus dem Weiterverkauf. Es könnten bis zu 7,7 Millionen USD nur erzielt werden, wenn alle ausstehenden Warrants bar ausgeübt werden; die Geschäftsleitung macht keine Vorhersage bezüglich Zeitpunkt oder Sicherheit.

Verwässerung/Überhang: Wenn alle zugrunde liegenden Wertpapiere umgewandelt oder ausgeübt werden, würden die ausstehenden Aktien um 23,6 % auf etwa 40,3 Millionen steigen, was die aktuellen Inhaber erheblich verwässert und den Free Float erweitert. Eine 9,99%-Besitzgrenze begrenzt Alphas Stimmrecht jederzeit.

  • Ausstehende Stammaktien (25.07.25): 32.563.677
  • Registrierung umfasst: 7.700.000 Aktien
  • Letzter Schlusskurs (29.07.25): 2,37 USD

Verwendung der Erlöse: Jegliche Bargelderlöse aus der Ausübung von Warrants würden für allgemeine Unternehmenszwecke verwendet. Risikofaktoren heben Verwässerung, Verkaufsdruck und zukünftigen Kapitalbedarf hervor.

Die Einreichung bewahrt die finanzielle Flexibilität, bringt jedoch potenzielle Gegenwinde durch das Aktienangebot, bis der Überhang absorbiert ist.

false 0000897723 0000897723 2025-07-29 2025-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

the Securities Exchange Act of 1934

 

July 29, 2025

Date of Report (date of earliest event reported)

 

SANMINA CORPORATION

(Exact name of registrant as specified in its charter)

 

DE   0-21272   77-0228183
(State or other jurisdiction of incorporation or
organization)
  (Commission File
Number)
 

(I.R.S. Employer Identification

No.)

 

2700 North First Street

San Jose, CA 95134

(Address of principal executive offices, including zip code)

 

(408) 964-3500

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class  Trading symbol(s)  Name of each exchange on which registered
Common Stock  SANM  NASDAQ Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

 

On July 29, 2025 (the “Signing Date”), Sanmina Corporation (the “Company”) entered into a Credit Agreement (the “Credit Agreement”), made by and among the Company, as the initial borrower, one of its subsidiaries named therein as a guarantor, Bank of America, N.A., as administrative agent (in such capacity, the “Agent”) and swing line lender, and the banks and other financial institutions party thereto from time to time as lenders (the “Lenders”) (and in certain cases, as letter of credit issuers as well). The Credit Agreement also includes the ability to add wholly owned subsidiaries of the Company as additional borrowers from time to time, subject to certain documentary requirements in the Credit Agreement.

 

The Credit Agreement provides for committed senior secured credit facilities in an aggregate principal amount of $3.5 billion (the “Credit Facilities”), consisting of a $1.5 billion revolving credit facility and a $2.0 billion term loan A facility. As of the Signing Date, the commitments under the Credit Agreement are completely unfunded, and the Company’s existing Fifth Amended and Restated Credit Agreement, dated as of September 27, 2022 (the “Existing Loan Agreement”), by and among the Company, the lenders party thereto, and Bank of America, N.A., as administrative agent, remains outstanding and the Company remains obligated under the Existing Loan Agreement.

 

The Credit Facilities will be initially drawn at the same time as the consummation of the previously disclosed acquisition of ZT Group Int’l, Inc. (“ZT” and such acquisition, the “ZT Acquisition”), and the proceeds of the Credit Facilities will be used initially (the date of such drawing, the “Initial Funding Date”), (a) in the case of the term loan A facility, to finance a portion of the ZT Acquisition, refinance ZT’s existing credit agreement (the “ZT Refinancing”), refinance all amounts outstanding under the Company’s Existing Loan Agreement (the “Sanmina Refinancing”) and to pay fees, costs and expenses relating thereto, and (b) in the case of the revolving credit facility, to fund original issue discount or upfront fees, for working capital and other adjustments in connection with the ZT Acquisition, to fund a portion of the ZT Acquisition, the ZT Refinancing and/or the Sanmina Refinancing, and to pay fees, costs and expenses relating thereto, to fund working capital needs and to replace existing letters of credit of the Company and ZT, as needed. Thereafter, the proceeds of the revolving credit facility will be used for general corporate purposes.

 

If the closing of the ZT Acquisition, and the initial funding of the Credit Facilities under the Credit Agreement, do not occur by the date that is the fifth (5th) business day following the “Outside Date” (as defined in the Equity Purchase Agreement, dated as of May 18, 2025, governing the ZT Acquisition, without giving effect to any amendment of such Equity Purchase Agreement) (the “Termination Date”) then the commitments under the Credit Facilities will terminate and no drawing may be made.

 

The borrowings under the Credit Facilities will mature, and the revolving facility commitments will terminate, five years from the Initial Funding Date, subject to extension as provided in the Credit Agreement. Borrowings under the Credit Agreement will bear interest, at the Company’s option, at either a base rate plus an applicable margin ranging from 0.375% to 1.000% or a term SOFR-based rate plus an applicable margin ranging from 1.375% to 2.000% (with the specific margin in effect from time to time within such range governed by a consolidated total net leverage ratio), in each case as set forth in the Credit Agreement. The Company expects that, at the time of the Initial Funding Date, based on the estimated consolidated total net leverage ratio at such time, the applicable margin for base rate and term SOFR-based rate borrowing would be 0.75% and 1.75%, respectively. The Company is also required to pay customary fees, including commitment fees (on the unused portion of the revolving facility) and letter of credit fees, as set forth in the Credit Agreement and related fee letters. During the period commencing on the 60th day following the Signing Date, and ending on (but not including) the Initial Funding Date or the Termination Date, whichever occurs firsts, the Company is required to pay to the Agent, for the ratable benefit of the Lenders, a ticking fee on the aggregate amount of the unfunded commitments under the Credit Facilities, at an annual rate of 0.25%, which ticking fees is payable regardless of whether the Initial Funding Date occurs.

 

Commencing on the Initial Funding Date, the obligations under the Credit Agreement will be secured by first-priority liens on substantially all of the assets of the Company and the subsidiary guarantors, subject to certain exceptions and thresholds. As of the Signing Date, such assets secure the obligations under the Existing Loan Agreement.

 

The Credit Agreement contains customary affirmative and negative covenants which will, commencing on the Initial Funding Date when such covenants go into effect, limit the ability of the Company and its subsidiaries to, among other things, incur debt, grant liens, make investments, make certain restricted payments, prepay subordinated indebtedness and sell assets, subject to certain exceptions and baskets. The Credit Agreement will also require, following the Initial Funding Date, that the Company comply with (i) a minimum consolidated cash interest coverage ratio of not less than 3.00 to 1.00 and (ii) a maximum consolidated total net leverage ratio of not greater than 4.00 to 1.00, in each case measured at the end of each fiscal quarter of the Company for the then-ended four fiscal quarter period.

 

 

 

 

Any of the borrowers may voluntarily prepay loans, and the Company may permanently reduce commitments under the Credit Agreement at any time in specified minimum principal amounts, without premium or penalty (but subject to payment of any applicable term SOFR (or alternative currency term rate) breakage costs).

 

The Credit Agreement also includes customary events of default, including payment defaults, cross defaults with certain other indebtedness, breaches of covenants or representations and warranties, change in control of the Company and certain bankruptcy or insolvency events. If at any time following the Initial Funding Date an event of default occurs and is continuing, the Agent and the lenders may, among other remedies, declare all outstanding obligations under the Credit Agreement to be immediately due and payable, terminate the lending commitments, require the Company to cash collateralize outstanding letters of credit, and exercise other rights and remedies available to secured creditors under the Credit Agreement and applicable law.

 

The foregoing description of the Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Credit Agreement, which the Company intends to file as an exhibit to its next periodic report filed with the Securities and Exchange Commission.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

 

Forward-Looking Statements

 

This Current Report on Form 8-K includes forward-looking statements concerning Sanmina Corporation, the ZT Acquisition, the Credit Facilities and other matters. These forward-looking statements address, among other things, anticipated future plans, objectives, strategies, events, results of operations, or financial condition, and are based on current expectations, estimates, and projections. Such statements involve risks and uncertainties that could cause actual results to differ materially from those anticipated. Forward-looking statements speak only as of the date they are made or as of the specific dates indicated in such statements. These statements should not be relied upon as guarantees or predictions of future events, as actual results or developments may differ materially from those projected or implied, and there can be no assurance that the events or circumstances reflected in these statements will be achieved or will occur. Forward-looking statements can often, but not always, be identified by the use of forward-looking terminology including “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “pro forma,” “estimates,” “anticipates,” “designed,” or the negative of these words and phrases, other variations of these words and phrases or comparable terminology. The forward-looking statements in this report relate to, among other things, the expected timing and completion of the ZT Acquisition, the satisfaction of the conditions for the Initial Funding Date to occur, the expected benefits of the Credit Facilities and the expected interest rates at the Initial Funding Date. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the statements. These risks include, among other things: failure to satisfy other closing conditions or to complete the ZT Acquisition on the anticipated terms or timeline, if at all; failure to satisfy the conditions for the Initial Funding Date to occur; failure to realize the expected benefits of the Credit Facilities; and the applicable interest rates at the Initial Funding Date being higher than expected. For a discussion of factors that could cause actual results to differ materially from those contemplated by forward-looking statements, see the section captioned “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024, subsequent Quarterly Reports on Form 10-Q, and other filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. The Company does not assume, and hereby disclaims, any obligation to update forward-looking statements, except as may be required by law.

 

 

 

 

SIGNATURE

 

Pursuant to the Requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  SANMINA CORPORATION
   
  By: /s/ Jonathan Faust
    Jonathan Faust
    Executive Vice President and Chief Financial Officer

 

Date:   July 30, 2025

 

 

 

FAQ

Why did AgEagle (UAVS) file this Form S-3?

To register 7.7 million shares for resale by Alpha Capital Anstalt, stemming from prior preferred stock and warrant issuances.

Does AgEagle receive any cash from the offering?

No cash from share sales; up to $7.7 million only if warrants are exercised for cash.

How much could existing shareholders be diluted?

Full conversion/exercise would increase shares outstanding by 23.6%, from 32.6 million to ~40.3 million.

What are the warrant exercise prices?

Ten warrant tranches range from $0.8294 to $2.19 per share.

What limits Alpha Capital’s control after conversion?

A 9.99% beneficial ownership blocker prevents Alpha from exceeding that threshold at any time.

What will AgEagle use potential warrant proceeds for?

Management states general corporate purposes.
Sanmina Corporat

NASDAQ:SANM

SANM Rankings

SANM Latest News

SANM Latest SEC Filings

SANM Stock Data

6.18B
51.63M
3.37%
100.5%
2.07%
Electronic Components
Printed Circuit Boards
Link
United States
SAN JOSE